Description
Indication & Scope
BeiYi® Losartan Potassium Tablets treats adult essential hypertension; adjuvant treatment of chronic heart failure for patients intolerant to ACEI drugs; Cozaar® Losartan Potassium Tablets treats essential hypertension; renal protective treatment for hypertension combined with type 2 diabetic nephropathy to delay renal function decline.
- Mechanism: Selectively blocks angiotensin II type 1 receptors, inhibits vasoconstriction and aldosterone secretion, reduces peripheral vascular resistance and blood pressure, and alleviates cardiac load.
- Drug class: Angiotensin II Receptor Blocker (ARB), antihypertensive agent.
- Clinical use: Long-term maintenance treatment for essential hypertension; alternative therapeutic intervention for ACEI-intolerant chronic heart failure patients.
| Generic Name | Losartan Potassium Tablets |
| Brand Name | BeiYi®; Cozaar® |
| Ingredient | Losartan Potassium |
| Dosage Form | Tablets |
| Package | BeiYi:
100mg*7 tablets*1 blisters/box; 100mg*7 tablets*2 blisters/box; 100mg*7 tablets*4 blisters/box; 50mg*7 tablets*1 blisters/box; 50mg*7 tablets*2 blisters/box; 50mg*7 tablets*3 blisters/box; 50mg*7 tablets*4 blisters/box Cozaar: 100mg*7 tablets/box; 100mg*28 tablets/box; 50mg*7 tablets/box; 50mg*14 tablets/box; 50mg*28 tablets/box; 12.5mg*7 tablets/box; 12.5mg*28 tablets/box |
| Conditions Treated | Adult essential hypertension, chronic heart failure (ACEI-intolerant cases); Essential hypertension, hypertension complicated with type 2 diabetic nephropathy |
| Taboos | Hypersensitivity to losartan potassium or tablet excipients; severe renal insufficiency; pregnancy and lactation period |
| Place of origin | China; Shotton Lane, Cramlington, NE23 3JU, United Kingdom |
| Prescription type | Prescription-only |
| Storage Conditions | Store at room temperature, keep tightly sealed, protect from moisture and strong light |
| Manufacturer | Zhejiang Huahai Pharmaceutical Co.,Ltd.; Organon Pharma (UK) Limited |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | H20143030; HJ20171245; HJ20202003 |
| Approval Date | May 25, 2022; Apr 21, 2022; Jul 3, 2023 |
| Shelf Life | 36 months |
How to use ?
Recommended Dose: 50mg once daily for hypertension treatment; dosage can be adjusted according to individual blood pressure response.
Time: Fixed daily time, independent of meal time.
Instructions for use: Swallow whole with warm water, do not crush or chew tablets, take continuously even with stable blood pressure.
Interaction: Combined use with potassium-sparing diuretics increases hyperkalemia risk; NSAIDs may reduce antihypertensive efficacy.
Side effects:
1. Common: mild dizziness, fatigue, orthostatic hypotension.
2. Rare: hyperkalemia, renal function fluctuation, upper respiratory tract discomfort.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What are the two main therapeutic applications of Losartan Potassium Tablets?
Long-term treatment of adult essential hypertension and adjuvant therapy for ACEI-intolerant chronic heart failure.
Why is Losartan Potassium Tablets suitable for specific heart failure patients?
It provides a safe alternative treatment for patients who cannot tolerate ACEI-class antihypertensive drugs.
What special groups are forbidden to take Losartan Potassium Tablets?
Pregnant women, lactating women and patients with severe renal insufficiency are contraindicated.
Does food intake affect the absorption and efficacy of Losartan Potassium Tablets?
Therapeutic effect is not affected by meal time, and administration can be fixed at any daily time.
BeiYi® | Losartan Potassium Tablets | Essential Hypertension/Chronic Heart Failure | DengYueRX
INN: Losartan Potassium Tablets
Indications: Essential hypertension, chronic heart failure/type 2 diabetes
Dosage Form: Tablets
Strength: 100mg/tablet
Price range: $2.40 through $9.54
